Skip to main content
76°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xenon Pharmaceuticals Inc
(NQ:
XENE
)
40.58
-0.18 (-0.44%)
Streaming Delayed Price
Updated: 11:21 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Xenon Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
The Latest Analyst Ratings for Xenon Pharmaceuticals
January 31, 2023
Via
Benzinga
Analyst Ratings for Xenon Pharmaceuticals
December 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 06, 2022
Via
Benzinga
Where Xenon Pharmaceuticals Stands With Analysts
November 28, 2022
Via
Benzinga
Analyst Sees This Epilepsy Player As 'M&A Sweet Spot'
October 19, 2022
Via
Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
October 11, 2022
Within the last quarter, Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Analyst Ratings for Xenon Pharmaceuticals
August 29, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
August 11, 2022
Within the last quarter, Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings:
Via
Benzinga
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
November 29, 2022
Xenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 92 Tuesday, up from 89 a day earlier.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via
Benzinga
Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing
November 09, 2022
Biotech stocks were hammered Wednesday, including several that had good news.
Via
Investor's Business Daily
Earnings Scheduled For November 8, 2022
November 08, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Via
Benzinga
Xenon's Epilepsy Candidate Rapidly Reduces Focal Onset Seizure Frequency
June 23, 2022
Via
Benzinga
Earnings Preview: Xenon Pharmaceuticals
November 07, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Xenon...
Via
Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
November 01, 2022
As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.
Via
InvestorPlace
Swing Trading Stock Watchlist For The Week Of Sept. 6
September 04, 2022
The overall stock market health is poor. I created a watchlist this week mainly to see how many stocks were forming quality contraction or cup-and-handle patterns. Let's take a look.
Via
Talk Markets
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
August 29, 2022
Xenon Pharmaceuticals Inc’s (NASDAQ: XENE) epilepsy candidate, XEN1101, is currently in phase III trials and “looks poised to be a blockbuster,” according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
August 29, 2022
Upgrades
Via
Benzinga
Xenon Pharmaceuticals Shares Drop On Proposed Public Offering
June 22, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Xenon Pharmaceuticals
August 11, 2022
Analysts have provided the following ratings for Xenon Pharmaceuticals (NASDAQ:XENE) within the last quarter:
Via
Benzinga
Xenon Pharmaceuticals: Q2 Earnings Insights
August 09, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 9, 2022
August 09, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Outlook For Xenon Pharmaceuticals
August 08, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022
July 21, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
June 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Xenon Pharma Flirted With A Breakout — And Then Sacrificed It All
June 23, 2022
The company had bullish results in seizure treatment. But it wasn't enough.
Via
Investor's Business Daily
US Stock Futures Mixed Ahead Of Jobless Claims, Powell Testimony
June 23, 2022
Pre-open movers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.